SAPIEN XT

DEVICE2 trials

Sponsors

Institut für Pharmakologie und Präventive Medizin, University of Padova

Conditions

Aortic Valve StenosisPulmonary Valve Malfunction

Unknown Phase

Pulmonic SAPIEN XT THV

CompletedNCT02302131

Institut für Pharmakologie und Präventive MedizinPulmonary Valve Malfunction

Start: 2014-11-30End: 2017-04-30Updated: 2017-04-05

Impact of SAVR and TAVR on Patient's Activity and Mobility

SuspendedNCT03843320

University of PadovaAortic Valve Stenosis

Start: 2021-12-31End: 2024-12-31Target: 340Updated: 2020-12-03

Related Papers

Using Wearable Devices to Monitor Physical Activity in Patients Undergoing Aortic Valve Replacement: Protocol for a Prospective Observational Study

JMIR Research Protocols2020-08-255 citations

Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN XT transcatheter heart valve system.

2017-10-0640 citations